Edesa Biotech (EDSA) Current Leases (2019 - 2024)
Edesa Biotech (EDSA) posted Current Leases of $19867.0 for Q3 2024, down 48.82% sequentially from $38817.0 in Q2 2024, and down 73.41% YoY from $74714.0 in Q4 2023.
Edesa Biotech (EDSA) Current Leases (2019 - 2024) Analysis & Trends
Edesa Biotech has reported Current Leases for 6 years, with the latest figure at $19867.0 in Q3 2024.
- Quarterly Current Leases fell 73.41% year-over-year to $19867.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $19867.0 (down 73.41% YoY) and the FY2024 annual result came in at $19867.0, down 73.41% from the prior year.
- Current Leases fell to $19867.0 in Q3 2024 per EDSA's latest filing, from $38817.0 in the prior quarter.
- Over five years, Current Leases peaked at $80167.0 in Q4 2021 and troughed at $18975.0 in Q3 2022.
- A 5-year average of $62639.9 and a median of $69730.0 in 2020 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases plunged 75.92% in 2022, then soared 293.75% in 2023.
- Over 5 years, Current Leases stood at $74877.0 in 2020, then increased by 7.06% to $80167.0 in 2021, then fell by 12.79% to $69911.0 in 2022, then rose by 12.02% to $78314.0 in 2023, then slumped by 74.63% to $19867.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $19867.0, $38817.0, and $58143.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Edesa Biotech | 41.75 Mn | 41.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 19,867.00 |
| Jun 30, 2024 | 38,817.00 |
| Mar 31, 2024 | 58,143.00 |
| Dec 31, 2023 | 78,314.00 |
| Sep 30, 2023 | 74,714.00 |
| Jun 30, 2023 | 74,846.00 |
| Mar 31, 2023 | 65,406.00 |
| Dec 31, 2022 | 69,911.00 |
| Sep 30, 2022 | 18,975.00 |
| Jun 30, 2022 | 40,123.00 |
| Mar 31, 2022 | 61,541.00 |
| Dec 31, 2021 | 80,167.00 |
| Sep 30, 2021 | 78,808.00 |
| Jun 30, 2021 | 79,503.00 |
| Mar 31, 2021 | 77,012.00 |
| Dec 31, 2020 | 74,877.00 |
| Sep 30, 2020 | 69,730.00 |
| Jun 30, 2020 | 66,709.00 |
| Mar 31, 2020 | 62,696.00 |
| Dec 31, 2019 | 66,631.00 |